Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Body Height | 29 | 2012 | 1577 | 2.150 |
Why?
|
Social Class | 35 | 2012 | 1999 | 1.990 |
Why?
|
Birth Weight | 28 | 2011 | 2069 | 1.080 |
Why?
|
Body Mass Index | 52 | 2011 | 12720 | 1.050 |
Why?
|
Coronary Disease | 22 | 2009 | 6077 | 0.910 |
Why?
|
Smoking | 26 | 2011 | 8987 | 0.830 |
Why?
|
Cause of Death | 14 | 2010 | 3584 | 0.820 |
Why?
|
Blood Pressure | 27 | 2012 | 8554 | 0.790 |
Why?
|
Obesity | 32 | 2011 | 12745 | 0.780 |
Why?
|
Lactase | 3 | 2010 | 69 | 0.770 |
Why?
|
Epidemiologic Research Design | 3 | 2012 | 367 | 0.770 |
Why?
|
Mortality | 10 | 2010 | 2864 | 0.750 |
Why?
|
Mendelian Randomization Analysis | 6 | 2012 | 967 | 0.740 |
Why?
|
Cardiovascular Diseases | 30 | 2012 | 15165 | 0.730 |
Why?
|
Genetic Variation | 17 | 2012 | 6544 | 0.710 |
Why?
|
Breast Feeding | 10 | 2011 | 1338 | 0.710 |
Why?
|
Socioeconomic Factors | 32 | 2012 | 7785 | 0.680 |
Why?
|
Intelligence | 8 | 2011 | 920 | 0.620 |
Why?
|
Income | 8 | 2011 | 1913 | 0.590 |
Why?
|
C-Reactive Protein | 12 | 2012 | 3778 | 0.570 |
Why?
|
Child Development | 9 | 2011 | 2223 | 0.570 |
Why?
|
Parents | 8 | 2012 | 3407 | 0.550 |
Why?
|
Polymorphism, Single Nucleotide | 39 | 2012 | 15519 | 0.550 |
Why?
|
Epidemiology | 2 | 2008 | 287 | 0.530 |
Why?
|
Educational Status | 13 | 2011 | 2540 | 0.530 |
Why?
|
Cohort Studies | 66 | 2012 | 40561 | 0.490 |
Why?
|
Poverty | 7 | 2011 | 2660 | 0.480 |
Why?
|
Overnutrition | 3 | 2008 | 26 | 0.470 |
Why?
|
Hypercholesterolemia | 5 | 2011 | 1151 | 0.470 |
Why?
|
Genotype | 36 | 2012 | 12951 | 0.470 |
Why?
|
Risk Factors | 78 | 2012 | 72290 | 0.450 |
Why?
|
Epidemiologic Methods | 7 | 2008 | 1364 | 0.450 |
Why?
|
Body Weight | 14 | 2011 | 4669 | 0.450 |
Why?
|
Overweight | 7 | 2011 | 2371 | 0.440 |
Why?
|
Scotland | 12 | 2010 | 155 | 0.420 |
Why?
|
Malnutrition | 3 | 2011 | 625 | 0.410 |
Why?
|
Diphtheria Antitoxin | 1 | 2011 | 6 | 0.410 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2011 | 284 | 0.400 |
Why?
|
Diphtheria | 1 | 2011 | 35 | 0.390 |
Why?
|
Lactose Intolerance | 2 | 2008 | 27 | 0.390 |
Why?
|
India | 11 | 2011 | 2197 | 0.380 |
Why?
|
England | 12 | 2012 | 522 | 0.380 |
Why?
|
Genetic Predisposition to Disease | 28 | 2011 | 17446 | 0.370 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2011 | 187 | 0.370 |
Why?
|
Lactose | 1 | 2010 | 95 | 0.370 |
Why?
|
Fibrinogen | 4 | 2006 | 894 | 0.360 |
Why?
|
Proteins | 9 | 2011 | 6103 | 0.360 |
Why?
|
Health Surveys | 14 | 2011 | 4037 | 0.360 |
Why?
|
Female | 150 | 2012 | 380194 | 0.350 |
Why?
|
Humans | 211 | 2012 | 744343 | 0.350 |
Why?
|
Genetic Loci | 8 | 2011 | 2575 | 0.350 |
Why?
|
Myocardial Ischemia | 4 | 2009 | 2148 | 0.350 |
Why?
|
Adiposity | 9 | 2011 | 1807 | 0.350 |
Why?
|
Meta-Analysis as Topic | 14 | 2011 | 1344 | 0.340 |
Why?
|
Middle Aged | 95 | 2012 | 213383 | 0.340 |
Why?
|
Male | 134 | 2012 | 350118 | 0.340 |
Why?
|
Polymorphism, Genetic | 12 | 2011 | 4328 | 0.330 |
Why?
|
Public Health | 3 | 2011 | 2603 | 0.330 |
Why?
|
Body Size | 5 | 2010 | 461 | 0.330 |
Why?
|
Child | 71 | 2012 | 77709 | 0.320 |
Why?
|
Embryonic and Fetal Development | 3 | 2004 | 438 | 0.320 |
Why?
|
Adult | 94 | 2012 | 214055 | 0.320 |
Why?
|
Cholesterol | 7 | 2012 | 2917 | 0.320 |
Why?
|
Child Nutritional Physiological Phenomena | 3 | 2011 | 303 | 0.320 |
Why?
|
Child Welfare | 3 | 2007 | 523 | 0.310 |
Why?
|
Genome-Wide Association Study | 20 | 2012 | 12261 | 0.310 |
Why?
|
Milk | 2 | 2010 | 450 | 0.310 |
Why?
|
Alcohol Drinking | 10 | 2010 | 3966 | 0.300 |
Why?
|
Molecular Epidemiology | 2 | 2008 | 468 | 0.300 |
Why?
|
Thinness | 3 | 2010 | 480 | 0.300 |
Why?
|
Life Style | 9 | 2008 | 3835 | 0.300 |
Why?
|
Absorptiometry, Photon | 7 | 2010 | 1725 | 0.300 |
Why?
|
Parent-Child Relations | 1 | 2012 | 747 | 0.300 |
Why?
|
Health Behavior | 4 | 2010 | 2636 | 0.290 |
Why?
|
Journal Impact Factor | 1 | 2008 | 156 | 0.290 |
Why?
|
Body Composition | 7 | 2010 | 2401 | 0.290 |
Why?
|
Maternal Welfare | 1 | 2007 | 115 | 0.290 |
Why?
|
Norway | 5 | 2008 | 448 | 0.290 |
Why?
|
Mothers | 7 | 2011 | 2165 | 0.290 |
Why?
|
Random Allocation | 2 | 2008 | 2429 | 0.280 |
Why?
|
Infant, Newborn | 32 | 2012 | 25625 | 0.280 |
Why?
|
Sanitation | 1 | 2007 | 93 | 0.280 |
Why?
|
Longitudinal Studies | 24 | 2012 | 13989 | 0.280 |
Why?
|
Body Fat Distribution | 2 | 2006 | 244 | 0.270 |
Why?
|
Hypertension | 13 | 2011 | 8480 | 0.270 |
Why?
|
Heredity | 1 | 2006 | 154 | 0.270 |
Why?
|
Blood Glucose | 8 | 2011 | 6256 | 0.260 |
Why?
|
Nutritional Status | 4 | 2008 | 1609 | 0.260 |
Why?
|
Prenatal Exposure Delayed Effects | 9 | 2010 | 2408 | 0.260 |
Why?
|
Homocysteine | 2 | 2011 | 647 | 0.250 |
Why?
|
Forced Expiratory Volume | 7 | 2011 | 1743 | 0.250 |
Why?
|
Body Constitution | 2 | 2007 | 278 | 0.250 |
Why?
|
Child Behavior | 1 | 2010 | 839 | 0.250 |
Why?
|
Housing | 2 | 2007 | 664 | 0.250 |
Why?
|
Odds Ratio | 14 | 2011 | 9849 | 0.240 |
Why?
|
Cross-Cultural Comparison | 1 | 2008 | 651 | 0.240 |
Why?
|
Aging | 12 | 2010 | 8664 | 0.240 |
Why?
|
Neural Tube Defects | 1 | 2006 | 256 | 0.240 |
Why?
|
Review Literature as Topic | 1 | 2006 | 336 | 0.230 |
Why?
|
Aged | 64 | 2012 | 163280 | 0.230 |
Why?
|
gamma-Glutamyltransferase | 4 | 2008 | 134 | 0.230 |
Why?
|
Causality | 6 | 2012 | 1275 | 0.230 |
Why?
|
Genome, Human | 7 | 2012 | 4420 | 0.230 |
Why?
|
Infant | 28 | 2012 | 35136 | 0.230 |
Why?
|
Health Status | 3 | 2011 | 4034 | 0.230 |
Why?
|
Child Behavior Disorders | 1 | 2008 | 807 | 0.230 |
Why?
|
Child Nutrition Disorders | 1 | 2005 | 149 | 0.230 |
Why?
|
Neoplasms | 13 | 2009 | 21683 | 0.220 |
Why?
|
Child, Preschool | 28 | 2012 | 41006 | 0.220 |
Why?
|
Proportional Hazards Models | 16 | 2010 | 12354 | 0.220 |
Why?
|
Pregnancy | 29 | 2012 | 29144 | 0.220 |
Why?
|
Women's Health | 5 | 2008 | 2034 | 0.220 |
Why?
|
Leg | 2 | 2011 | 1116 | 0.220 |
Why?
|
Estrogen Replacement Therapy | 2 | 2006 | 1203 | 0.220 |
Why?
|
Social Justice | 1 | 2007 | 456 | 0.220 |
Why?
|
Psychophysiologic Disorders | 1 | 2004 | 228 | 0.220 |
Why?
|
Stroke | 9 | 2011 | 9981 | 0.210 |
Why?
|
Data Interpretation, Statistical | 4 | 2011 | 2716 | 0.210 |
Why?
|
Adolescent | 46 | 2012 | 85781 | 0.210 |
Why?
|
Parenting | 1 | 2008 | 679 | 0.210 |
Why?
|
Rural Health | 4 | 2010 | 305 | 0.210 |
Why?
|
Benchmarking | 1 | 2008 | 1042 | 0.210 |
Why?
|
Estrogen Receptor alpha | 1 | 2006 | 577 | 0.200 |
Why?
|
Quantitative Trait Loci | 6 | 2012 | 2019 | 0.200 |
Why?
|
Occupations | 5 | 2005 | 517 | 0.200 |
Why?
|
Diabetes Complications | 1 | 2008 | 1359 | 0.200 |
Why?
|
Alanine Transaminase | 4 | 2008 | 592 | 0.190 |
Why?
|
Cerebral Infarction | 2 | 2003 | 1011 | 0.190 |
Why?
|
Soccer | 1 | 2002 | 133 | 0.190 |
Why?
|
Fasting | 5 | 2011 | 1593 | 0.190 |
Why?
|
Tooth, Deciduous | 2 | 2011 | 74 | 0.190 |
Why?
|
Folic Acid | 4 | 2011 | 1300 | 0.190 |
Why?
|
Insulin | 5 | 2008 | 6580 | 0.190 |
Why?
|
Cluster Analysis | 1 | 2007 | 2715 | 0.190 |
Why?
|
Waist-Hip Ratio | 4 | 2011 | 517 | 0.190 |
Why?
|
Hormone Replacement Therapy | 1 | 2006 | 745 | 0.180 |
Why?
|
Confidence Intervals | 7 | 2008 | 2971 | 0.180 |
Why?
|
Obstetrics | 1 | 2007 | 658 | 0.180 |
Why?
|
Cholesterol, HDL | 2 | 2006 | 1814 | 0.180 |
Why?
|
Prospective Studies | 31 | 2011 | 53288 | 0.180 |
Why?
|
Intermediate Filament Proteins | 3 | 2011 | 269 | 0.180 |
Why?
|
Health Status Disparities | 2 | 2010 | 1797 | 0.180 |
Why?
|
Weight Gain | 4 | 2011 | 2292 | 0.180 |
Why?
|
Follow-Up Studies | 24 | 2011 | 39050 | 0.180 |
Why?
|
Apolipoproteins E | 3 | 2011 | 1438 | 0.170 |
Why?
|
Finland | 8 | 2010 | 602 | 0.170 |
Why?
|
Chromosomes, Human, Pair 15 | 2 | 2011 | 373 | 0.170 |
Why?
|
Prevalence | 15 | 2011 | 15226 | 0.170 |
Why?
|
Stress, Psychological | 5 | 2012 | 4245 | 0.170 |
Why?
|
Testosterone | 2 | 2010 | 2420 | 0.170 |
Why?
|
Gestational Age | 8 | 2010 | 3493 | 0.160 |
Why?
|
Suicide | 1 | 2009 | 1477 | 0.160 |
Why?
|
Angina Pectoris | 1 | 2002 | 977 | 0.160 |
Why?
|
Gene Frequency | 6 | 2011 | 3588 | 0.160 |
Why?
|
History, 19th Century | 2 | 2011 | 720 | 0.160 |
Why?
|
Fetus | 4 | 2010 | 1880 | 0.160 |
Why?
|
Risk-Taking | 2 | 2003 | 986 | 0.150 |
Why?
|
Growth | 3 | 2011 | 376 | 0.150 |
Why?
|
Menopause | 3 | 2004 | 1626 | 0.150 |
Why?
|
Anthropometry | 6 | 2010 | 1350 | 0.150 |
Why?
|
Hydrocortisone | 1 | 2005 | 1826 | 0.150 |
Why?
|
Age Factors | 14 | 2011 | 18370 | 0.150 |
Why?
|
Vulnerable Populations | 1 | 2003 | 687 | 0.150 |
Why?
|
Tunica Intima | 4 | 2008 | 464 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2010 | 11725 | 0.140 |
Why?
|
Menarche | 2 | 2010 | 516 | 0.140 |
Why?
|
Intelligence Tests | 4 | 2011 | 505 | 0.140 |
Why?
|
Breast | 2 | 2009 | 1969 | 0.140 |
Why?
|
Parity | 3 | 2004 | 929 | 0.140 |
Why?
|
Vital Capacity | 4 | 2011 | 925 | 0.140 |
Why?
|
Kidney Neoplasms | 2 | 2010 | 4262 | 0.140 |
Why?
|
History, 20th Century | 3 | 2011 | 2740 | 0.140 |
Why?
|
Patient Admission | 2 | 2005 | 1380 | 0.140 |
Why?
|
Brazil | 2 | 2011 | 1270 | 0.130 |
Why?
|
Korea | 4 | 2009 | 99 | 0.130 |
Why?
|
Smoking Cessation | 2 | 2009 | 2071 | 0.130 |
Why?
|
Students | 2 | 2002 | 1654 | 0.130 |
Why?
|
Exercise | 8 | 2010 | 5615 | 0.130 |
Why?
|
Tooth Eruption | 2 | 2011 | 30 | 0.130 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 3143 | 0.130 |
Why?
|
Phenotype | 12 | 2012 | 16365 | 0.130 |
Why?
|
Maternal Age | 2 | 2008 | 802 | 0.120 |
Why?
|
Receptor, Melanocortin, Type 4 | 3 | 2011 | 129 | 0.120 |
Why?
|
Heart Diseases | 1 | 2007 | 2788 | 0.120 |
Why?
|
Linear Models | 10 | 2011 | 5952 | 0.120 |
Why?
|
Haptoglobins | 2 | 2012 | 165 | 0.120 |
Why?
|
Medical Record Linkage | 2 | 2005 | 284 | 0.120 |
Why?
|
Infant, Low Birth Weight | 3 | 2009 | 850 | 0.120 |
Why?
|
Alleles | 12 | 2012 | 6933 | 0.120 |
Why?
|
Attitude to Health | 1 | 2003 | 2052 | 0.120 |
Why?
|
Mammography | 1 | 2004 | 2476 | 0.110 |
Why?
|
Cross-Sectional Studies | 18 | 2012 | 25043 | 0.110 |
Why?
|
Nerve Tissue Proteins | 4 | 2011 | 4462 | 0.110 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2008 | 2015 | 0.110 |
Why?
|
Infant Nutritional Physiological Phenomena | 3 | 2005 | 347 | 0.110 |
Why?
|
Milk, Human | 2 | 2010 | 490 | 0.110 |
Why?
|
Sex Factors | 9 | 2011 | 10397 | 0.110 |
Why?
|
Denmark | 3 | 2011 | 738 | 0.110 |
Why?
|
Europe | 5 | 2011 | 3339 | 0.110 |
Why?
|
Tunica Media | 3 | 2008 | 113 | 0.110 |
Why?
|
Insulin Resistance | 5 | 2007 | 3864 | 0.110 |
Why?
|
Risk Assessment | 15 | 2011 | 23338 | 0.110 |
Why?
|
Urban Population | 3 | 2011 | 2021 | 0.110 |
Why?
|
Age Distribution | 5 | 2010 | 2902 | 0.110 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2012 | 39 | 0.110 |
Why?
|
Observation | 2 | 2012 | 312 | 0.100 |
Why?
|
Occupational Exposure | 1 | 2002 | 1796 | 0.100 |
Why?
|
Mental Disorders | 3 | 2012 | 6600 | 0.100 |
Why?
|
Registries | 5 | 2009 | 8089 | 0.100 |
Why?
|
Employment | 3 | 2010 | 1132 | 0.100 |
Why?
|
Coronary Artery Disease | 4 | 2010 | 6487 | 0.100 |
Why?
|
Transcription Initiation Site | 1 | 2012 | 196 | 0.100 |
Why?
|
Fetal Development | 2 | 2008 | 767 | 0.100 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 5 | 2011 | 3047 | 0.100 |
Why?
|
Thrombosis | 1 | 2005 | 2968 | 0.100 |
Why?
|
Young Adult | 13 | 2011 | 56430 | 0.100 |
Why?
|
Body Weights and Measures | 1 | 2012 | 211 | 0.100 |
Why?
|
Paired Box Transcription Factors | 1 | 2012 | 215 | 0.100 |
Why?
|
Calcifediol | 1 | 2012 | 166 | 0.100 |
Why?
|
Famous Persons | 1 | 2012 | 108 | 0.100 |
Why?
|
Adipose Tissue | 8 | 2010 | 3279 | 0.100 |
Why?
|
Case-Control Studies | 11 | 2011 | 21746 | 0.090 |
Why?
|
Cotinine | 1 | 2011 | 206 | 0.090 |
Why?
|
Incidence | 10 | 2008 | 20947 | 0.090 |
Why?
|
Facial Bones | 1 | 2012 | 201 | 0.090 |
Why?
|
History, 17th Century | 1 | 2010 | 111 | 0.090 |
Why?
|
Risk | 6 | 2011 | 9687 | 0.090 |
Why?
|
Genetics, Population | 3 | 2012 | 934 | 0.090 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 367 | 0.090 |
Why?
|
Respiratory Function Tests | 2 | 2011 | 1616 | 0.090 |
Why?
|
Receptors, Nicotinic | 2 | 2011 | 497 | 0.090 |
Why?
|
Blood Pressure Determination | 2 | 2011 | 634 | 0.090 |
Why?
|
Logistic Models | 7 | 2008 | 13408 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 3870 | 0.090 |
Why?
|
Healthy People Programs | 1 | 2009 | 53 | 0.090 |
Why?
|
Vascular Resistance | 2 | 2010 | 936 | 0.090 |
Why?
|
Time Factors | 10 | 2012 | 40075 | 0.080 |
Why?
|
Vitamin B Complex | 1 | 2011 | 288 | 0.080 |
Why?
|
Wales | 3 | 2003 | 85 | 0.080 |
Why?
|
Gene Dosage | 2 | 2011 | 1252 | 0.080 |
Why?
|
Urban Health | 3 | 2006 | 547 | 0.080 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2008 | 49 | 0.080 |
Why?
|
Carotid Arteries | 3 | 2010 | 952 | 0.080 |
Why?
|
Vietnam | 1 | 2009 | 408 | 0.080 |
Why?
|
Dietary Supplements | 4 | 2011 | 3297 | 0.080 |
Why?
|
Hemoglobins | 2 | 2012 | 1534 | 0.080 |
Why?
|
Carotid Artery Diseases | 2 | 2005 | 882 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2011 | 9959 | 0.080 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2012 | 794 | 0.080 |
Why?
|
Environment | 3 | 2011 | 1124 | 0.080 |
Why?
|
Maternal Nutritional Physiological Phenomena | 2 | 2008 | 378 | 0.080 |
Why?
|
Censuses | 2 | 2008 | 200 | 0.080 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2009 | 380 | 0.080 |
Why?
|
Gravidity | 1 | 2007 | 51 | 0.080 |
Why?
|
Iron, Dietary | 1 | 2008 | 141 | 0.080 |
Why?
|
Caribbean Region | 1 | 2008 | 194 | 0.080 |
Why?
|
Regression Analysis | 8 | 2011 | 6459 | 0.080 |
Why?
|
Data Collection | 3 | 2008 | 3341 | 0.080 |
Why?
|
Chromosome Mapping | 3 | 2010 | 4740 | 0.080 |
Why?
|
Population Groups | 1 | 2008 | 209 | 0.080 |
Why?
|
Urbanization | 1 | 2008 | 104 | 0.070 |
Why?
|
Carotid Artery, Common | 1 | 2008 | 183 | 0.070 |
Why?
|
Pakistan | 1 | 2008 | 295 | 0.070 |
Why?
|
Republic of Belarus | 3 | 2011 | 38 | 0.070 |
Why?
|
von Willebrand Factor | 1 | 2011 | 669 | 0.070 |
Why?
|
Genetic Heterogeneity | 1 | 2010 | 733 | 0.070 |
Why?
|
Lipids | 4 | 2012 | 3305 | 0.070 |
Why?
|
Kallikreins | 1 | 2008 | 258 | 0.070 |
Why?
|
Fingers | 1 | 2010 | 513 | 0.070 |
Why?
|
Genetic Linkage | 2 | 2012 | 2421 | 0.070 |
Why?
|
Stomach Neoplasms | 3 | 2007 | 1333 | 0.070 |
Why?
|
Parturition | 2 | 2010 | 441 | 0.070 |
Why?
|
Nicotinic Agonists | 1 | 2008 | 271 | 0.070 |
Why?
|
Bone Density | 2 | 2010 | 3468 | 0.070 |
Why?
|
Universities | 2 | 2002 | 956 | 0.070 |
Why?
|
INDEL Mutation | 1 | 2008 | 279 | 0.070 |
Why?
|
Maternal Behavior | 1 | 2009 | 311 | 0.070 |
Why?
|
Homozygote | 2 | 2008 | 1785 | 0.070 |
Why?
|
Sweden | 2 | 2009 | 1345 | 0.070 |
Why?
|
Mental Processes | 1 | 2007 | 249 | 0.070 |
Why?
|
Eczema | 1 | 2008 | 231 | 0.070 |
Why?
|
Social Facilitation | 1 | 2005 | 31 | 0.070 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2008 | 365 | 0.070 |
Why?
|
Puberty | 1 | 2009 | 490 | 0.070 |
Why?
|
Rural Population | 3 | 2011 | 2210 | 0.070 |
Why?
|
Myocardial Infarction | 2 | 2008 | 11727 | 0.070 |
Why?
|
Sodium, Dietary | 2 | 2010 | 418 | 0.070 |
Why?
|
Haplotypes | 3 | 2007 | 2779 | 0.070 |
Why?
|
Child Mortality | 1 | 2008 | 198 | 0.070 |
Why?
|
Infant Mortality | 2 | 2008 | 754 | 0.070 |
Why?
|
Psychology | 1 | 2007 | 356 | 0.070 |
Why?
|
Pregnancy Complications | 3 | 2008 | 2861 | 0.070 |
Why?
|
Marriage | 1 | 2007 | 339 | 0.070 |
Why?
|
Lipoproteins | 2 | 2011 | 878 | 0.060 |
Why?
|
Predictive Value of Tests | 5 | 2011 | 15076 | 0.060 |
Why?
|
Atherosclerosis | 4 | 2010 | 3445 | 0.060 |
Why?
|
Forecasting | 2 | 2012 | 2951 | 0.060 |
Why?
|
Marijuana Smoking | 1 | 2008 | 253 | 0.060 |
Why?
|
Diabetes Mellitus | 6 | 2010 | 5751 | 0.060 |
Why?
|
Dermatitis, Atopic | 1 | 2011 | 654 | 0.060 |
Why?
|
Sodium | 1 | 2010 | 1623 | 0.060 |
Why?
|
Metabolic Diseases | 1 | 2011 | 658 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2008 | 604 | 0.060 |
Why?
|
Aryldialkylphosphatase | 1 | 2004 | 63 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1025 | 0.060 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2008 | 365 | 0.060 |
Why?
|
Breast Neoplasms | 5 | 2007 | 20822 | 0.060 |
Why?
|
Dehydration | 1 | 2006 | 234 | 0.060 |
Why?
|
Linkage Disequilibrium | 4 | 2011 | 1997 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2012 | 12072 | 0.060 |
Why?
|
Dairy Products | 1 | 2007 | 498 | 0.060 |
Why?
|
Cerebral Hemorrhage | 2 | 2008 | 2647 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6171 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2012 | 1988 | 0.060 |
Why?
|
RNA-Binding Proteins | 2 | 2010 | 1903 | 0.060 |
Why?
|
Nicotine | 1 | 2008 | 681 | 0.060 |
Why?
|
London | 3 | 2010 | 233 | 0.060 |
Why?
|
Life Expectancy | 1 | 2010 | 1184 | 0.060 |
Why?
|
Sensitivity and Specificity | 4 | 2007 | 14722 | 0.060 |
Why?
|
Evidence-Based Medicine | 3 | 2011 | 3610 | 0.060 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 1125 | 0.060 |
Why?
|
Infant Formula | 1 | 2005 | 199 | 0.060 |
Why?
|
Leptin | 2 | 2012 | 1599 | 0.060 |
Why?
|
Lung | 3 | 2011 | 9856 | 0.060 |
Why?
|
Models, Statistical | 4 | 2011 | 5102 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2010 | 832 | 0.060 |
Why?
|
Multivariate Analysis | 5 | 2011 | 12245 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 424 | 0.060 |
Why?
|
Minisatellite Repeats | 1 | 2004 | 165 | 0.060 |
Why?
|
Bereavement | 1 | 2007 | 277 | 0.060 |
Why?
|
Eating | 2 | 2007 | 1536 | 0.060 |
Why?
|
Aortic Aneurysm | 1 | 2008 | 643 | 0.060 |
Why?
|
Genetic Markers | 1 | 2009 | 2634 | 0.050 |
Why?
|
Disease | 1 | 2008 | 680 | 0.050 |
Why?
|
Hair Removal | 1 | 2003 | 42 | 0.050 |
Why?
|
Selection, Genetic | 1 | 2007 | 914 | 0.050 |
Why?
|
Environmental Exposure | 3 | 2007 | 4234 | 0.050 |
Why?
|
Heterozygote | 1 | 2009 | 2804 | 0.050 |
Why?
|
Hyperlipoproteinemia Type II | 2 | 2005 | 373 | 0.050 |
Why?
|
Death | 1 | 2007 | 678 | 0.050 |
Why?
|
Interleukin-6 | 2 | 2012 | 3200 | 0.050 |
Why?
|
Brain Ischemia | 2 | 2008 | 3265 | 0.050 |
Why?
|
Ethanol | 1 | 2008 | 1342 | 0.050 |
Why?
|
Hearing Disorders | 1 | 2002 | 124 | 0.050 |
Why?
|
Vitamin B 6 | 1 | 2003 | 237 | 0.050 |
Why?
|
Motor Activity | 3 | 2009 | 2714 | 0.050 |
Why?
|
Family Characteristics | 2 | 2006 | 1000 | 0.050 |
Why?
|
Siblings | 1 | 2006 | 854 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2212 | 0.050 |
Why?
|
Diarrhea | 2 | 2006 | 1348 | 0.050 |
Why?
|
Central Nervous System | 1 | 2008 | 1357 | 0.050 |
Why?
|
Health Status Indicators | 2 | 2004 | 969 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2010 | 1861 | 0.050 |
Why?
|
Drug Prescriptions | 1 | 2011 | 1637 | 0.050 |
Why?
|
Receptors, Serotonin, 5-HT4 | 2 | 2011 | 16 | 0.050 |
Why?
|
Glutamine | 1 | 2004 | 578 | 0.050 |
Why?
|
Energy Intake | 1 | 2009 | 2148 | 0.050 |
Why?
|
Calcium, Dietary | 1 | 2004 | 526 | 0.050 |
Why?
|
Memory | 1 | 2011 | 2174 | 0.050 |
Why?
|
Fathers | 3 | 2011 | 358 | 0.050 |
Why?
|
Hyperinsulinism | 1 | 2004 | 415 | 0.050 |
Why?
|
Homeostasis | 2 | 2010 | 3340 | 0.050 |
Why?
|
DNA-Binding Proteins | 4 | 2011 | 9648 | 0.050 |
Why?
|
Aorta | 1 | 2008 | 2061 | 0.050 |
Why?
|
Osteoporosis | 1 | 2010 | 1580 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2008 | 1782 | 0.050 |
Why?
|
Family | 3 | 2011 | 3147 | 0.050 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2002 | 369 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2010 | 2050 | 0.050 |
Why?
|
Sexual Behavior | 1 | 2010 | 2057 | 0.050 |
Why?
|
Arginine | 1 | 2004 | 944 | 0.050 |
Why?
|
Arteriosclerosis | 1 | 2005 | 1092 | 0.050 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2008 | 1018 | 0.050 |
Why?
|
Comorbidity | 2 | 2012 | 10388 | 0.040 |
Why?
|
Hemodynamics | 1 | 2010 | 4199 | 0.040 |
Why?
|
Anxiety Disorders | 1 | 2011 | 2690 | 0.040 |
Why?
|
Lung Neoplasms | 3 | 2011 | 13102 | 0.040 |
Why?
|
Bone and Bones | 1 | 2010 | 2575 | 0.040 |
Why?
|
International Cooperation | 1 | 2006 | 1420 | 0.040 |
Why?
|
Liver Diseases | 1 | 2008 | 1253 | 0.040 |
Why?
|
Testicular Neoplasms | 1 | 2005 | 804 | 0.040 |
Why?
|
Prostatic Neoplasms | 3 | 2009 | 11124 | 0.040 |
Why?
|
Survival Rate | 2 | 2010 | 12788 | 0.040 |
Why?
|
Cognition | 3 | 2011 | 6770 | 0.040 |
Why?
|
Glutathione Transferase | 2 | 2011 | 595 | 0.040 |
Why?
|
Uncertainty | 1 | 2003 | 734 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2010 | 19905 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2006 | 2795 | 0.040 |
Why?
|
Research Design | 2 | 2012 | 5987 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2009 | 298 | 0.040 |
Why?
|
Transcription Factors | 4 | 2011 | 12208 | 0.040 |
Why?
|
DNA Copy Number Variations | 3 | 2011 | 1941 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4456 | 0.040 |
Why?
|
Respiratory Tract Infections | 1 | 2005 | 961 | 0.040 |
Why?
|
Spirometry | 2 | 2011 | 864 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3703 | 0.040 |
Why?
|
Chronic Disease | 2 | 2009 | 9146 | 0.040 |
Why?
|
Colorectal Neoplasms | 3 | 2007 | 6773 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4186 | 0.040 |
Why?
|
Lung Diseases | 1 | 2006 | 1886 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 2 | 2010 | 544 | 0.030 |
Why?
|
Education | 2 | 2011 | 543 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3255 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5853 | 0.030 |
Why?
|
Blood Flow Velocity | 2 | 2010 | 1423 | 0.030 |
Why?
|
Health Promotion | 2 | 2010 | 2205 | 0.030 |
Why?
|
Chest Pain | 1 | 2002 | 1114 | 0.030 |
Why?
|
Postmenopause | 1 | 2004 | 2461 | 0.030 |
Why?
|
Prognosis | 3 | 2011 | 29063 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 3658 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2009 | 2734 | 0.030 |
Why?
|
Microfilament Proteins | 2 | 2011 | 1152 | 0.030 |
Why?
|
Adiponectin | 2 | 2012 | 1100 | 0.030 |
Why?
|
Sex Characteristics | 3 | 2010 | 2585 | 0.030 |
Why?
|
Mutation | 3 | 2009 | 29786 | 0.030 |
Why?
|
Receptors, Immunologic | 2 | 2011 | 1423 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2002 | 1881 | 0.030 |
Why?
|
Cephalometry | 2 | 2007 | 382 | 0.030 |
Why?
|
Air Pollution | 1 | 2007 | 2286 | 0.030 |
Why?
|
Endpoint Determination | 2 | 2007 | 601 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2009 | 77449 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9438 | 0.030 |
Why?
|
Population Surveillance | 3 | 2011 | 2616 | 0.030 |
Why?
|
Asthma | 1 | 2011 | 6011 | 0.030 |
Why?
|
Nasal Bone | 1 | 2012 | 58 | 0.030 |
Why?
|
Liver | 1 | 2008 | 7474 | 0.030 |
Why?
|
Organ Size | 2 | 2009 | 2252 | 0.030 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2011 | 133 | 0.030 |
Why?
|
United States | 5 | 2011 | 69872 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2002 | 1432 | 0.020 |
Why?
|
Transcription Factor AP-2 | 1 | 2011 | 82 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 2011 | 73 | 0.020 |
Why?
|
Glucose Transporter Type 2 | 1 | 2011 | 62 | 0.020 |
Why?
|
Cryptochromes | 1 | 2011 | 45 | 0.020 |
Why?
|
Anxiety | 2 | 2003 | 4297 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 5256 | 0.020 |
Why?
|
Dissent and Disputes | 1 | 2012 | 141 | 0.020 |
Why?
|
Maternal Exposure | 2 | 2009 | 961 | 0.020 |
Why?
|
Depression | 2 | 2008 | 7766 | 0.020 |
Why?
|
HMGA2 Protein | 1 | 2011 | 123 | 0.020 |
Why?
|
Tuberculosis | 1 | 2004 | 1912 | 0.020 |
Why?
|
Nucleic Acid Denaturation | 1 | 2011 | 111 | 0.020 |
Why?
|
Interleukin-11 | 1 | 2010 | 63 | 0.020 |
Why?
|
Carcinoma, Large Cell | 1 | 2011 | 113 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2003 | 1832 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2011 | 57776 | 0.020 |
Why?
|
Emotions | 1 | 2002 | 2661 | 0.020 |
Why?
|
Base Pairing | 1 | 2011 | 141 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2003 | 3748 | 0.020 |
Why?
|
Hospitals, Psychiatric | 1 | 2012 | 332 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2011 | 417 | 0.020 |
Why?
|
Gambia | 1 | 2010 | 98 | 0.020 |
Why?
|
Homeodomain Proteins | 2 | 2011 | 2421 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2010 | 180 | 0.020 |
Why?
|
Economics | 1 | 2011 | 146 | 0.020 |
Why?
|
Soybean Oil | 1 | 2011 | 133 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2011 | 403 | 0.020 |
Why?
|
Reference Values | 2 | 2008 | 4982 | 0.020 |
Why?
|
Twin Studies as Topic | 1 | 2010 | 105 | 0.020 |
Why?
|
Thrombospondin 1 | 1 | 2011 | 250 | 0.020 |
Why?
|
Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2009 | 17 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2002 | 3589 | 0.020 |
Why?
|
Chemokines, CC | 1 | 2011 | 291 | 0.020 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2009 | 30 | 0.020 |
Why?
|
Glycine Hydroxymethyltransferase | 1 | 2009 | 32 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2012 | 421 | 0.020 |
Why?
|
Apolipoproteins | 1 | 2012 | 317 | 0.020 |
Why?
|
Nuclear Family | 1 | 2010 | 318 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2002 | 3188 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2012 | 365 | 0.020 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2009 | 77 | 0.020 |
Why?
|
Electrocardiography | 1 | 2002 | 6442 | 0.020 |
Why?
|
Thrombospondins | 1 | 2009 | 197 | 0.020 |
Why?
|
tRNA Methyltransferases | 1 | 2009 | 53 | 0.020 |
Why?
|
Cholesterol, LDL | 2 | 2011 | 2356 | 0.020 |
Why?
|
ABO Blood-Group System | 1 | 2011 | 367 | 0.020 |
Why?
|
Epidermis | 1 | 2011 | 528 | 0.020 |
Why?
|
Genitalia | 1 | 2009 | 112 | 0.020 |
Why?
|
Founder Effect | 1 | 2009 | 189 | 0.020 |
Why?
|
Systole | 1 | 2011 | 958 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2010 | 340 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2009 | 112 | 0.020 |
Why?
|
Potassium Channels | 1 | 2011 | 563 | 0.020 |
Why?
|
Diastole | 1 | 2011 | 791 | 0.020 |
Why?
|
Brachial Artery | 1 | 2010 | 369 | 0.020 |
Why?
|
Vasomotor System | 1 | 2009 | 209 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2010 | 456 | 0.020 |
Why?
|
Genetic Techniques | 1 | 2011 | 435 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2003 | 3923 | 0.020 |
Why?
|
France | 1 | 2009 | 517 | 0.020 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2008 | 245 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2011 | 723 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2009 | 513 | 0.020 |
Why?
|
Tympanic Membrane | 1 | 2009 | 225 | 0.020 |
Why?
|
Diet Records | 1 | 2009 | 425 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2009 | 462 | 0.020 |
Why?
|
Neurotransmitter Agents | 1 | 2011 | 647 | 0.020 |
Why?
|
Queensland | 1 | 2006 | 37 | 0.020 |
Why?
|
Elasticity | 1 | 2008 | 657 | 0.020 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2011 | 388 | 0.020 |
Why?
|
Menstruation | 1 | 2008 | 302 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2012 | 921 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2892 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2008 | 528 | 0.020 |
Why?
|
Sample Size | 1 | 2009 | 845 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 950 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2618 | 0.020 |
Why?
|
Waist Circumference | 1 | 2010 | 917 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1157 | 0.020 |
Why?
|
Vasodilation | 1 | 2010 | 944 | 0.020 |
Why?
|
MEDLINE | 1 | 2006 | 125 | 0.020 |
Why?
|
Dietary Proteins | 1 | 2011 | 963 | 0.020 |
Why?
|
Hair | 1 | 2009 | 483 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2006 | 467 | 0.020 |
Why?
|
Human Genome Project | 1 | 2006 | 193 | 0.020 |
Why?
|
Hearing | 1 | 2009 | 482 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2008 | 1525 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1504 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2010 | 575 | 0.020 |
Why?
|
Weather | 1 | 2006 | 228 | 0.020 |
Why?
|
Tobacco Use Disorder | 1 | 2010 | 688 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2008 | 865 | 0.020 |
Why?
|
Monitoring, Ambulatory | 1 | 2008 | 355 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2011 | 7880 | 0.020 |
Why?
|
Codon | 1 | 2006 | 611 | 0.020 |
Why?
|
Motor Skills | 1 | 2007 | 522 | 0.010 |
Why?
|
Canada | 1 | 2009 | 2065 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2009 | 13033 | 0.010 |
Why?
|
Morbidity | 1 | 2009 | 1769 | 0.010 |
Why?
|
Embryonic Development | 1 | 2008 | 711 | 0.010 |
Why?
|
Public Sector | 1 | 2005 | 265 | 0.010 |
Why?
|
Diabetic Angiopathies | 1 | 2008 | 818 | 0.010 |
Why?
|
Spine | 1 | 2010 | 1144 | 0.010 |
Why?
|
Dyslipidemias | 1 | 2010 | 849 | 0.010 |
Why?
|
Government Agencies | 1 | 2003 | 156 | 0.010 |
Why?
|
Urocortins | 1 | 2002 | 19 | 0.010 |
Why?
|
Receptors, LDL | 1 | 2005 | 475 | 0.010 |
Why?
|
Child Rearing | 1 | 2003 | 74 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1801 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1783 | 0.010 |
Why?
|
Fibrin | 1 | 2005 | 506 | 0.010 |
Why?
|
Exons | 1 | 2008 | 2437 | 0.010 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2004 | 271 | 0.010 |
Why?
|
Fruit | 1 | 2007 | 1142 | 0.010 |
Why?
|
Vegetables | 1 | 2007 | 1182 | 0.010 |
Why?
|
Hearing Loss | 1 | 2009 | 765 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2703 | 0.010 |
Why?
|
Animals | 3 | 2010 | 168757 | 0.010 |
Why?
|
Patient Compliance | 1 | 2012 | 2684 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2007 | 1364 | 0.010 |
Why?
|
Alcoholism | 1 | 2012 | 1906 | 0.010 |
Why?
|
Geography | 1 | 2004 | 669 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3271 | 0.010 |
Why?
|
Genes, BRCA1 | 1 | 2005 | 781 | 0.010 |
Why?
|
National Health Programs | 1 | 2005 | 445 | 0.010 |
Why?
|
Marital Status | 1 | 2003 | 437 | 0.010 |
Why?
|
Self-Assessment | 1 | 2003 | 390 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6365 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2006 | 1730 | 0.010 |
Why?
|
Trans-Activators | 1 | 2011 | 2924 | 0.010 |
Why?
|
Family Health | 1 | 2006 | 1282 | 0.010 |
Why?
|
Italy | 1 | 2003 | 832 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2531 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2849 | 0.010 |
Why?
|
Brain | 1 | 2007 | 26385 | 0.010 |
Why?
|
Mother-Child Relations | 1 | 2004 | 481 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2010 | 5078 | 0.010 |
Why?
|
Iron | 1 | 2008 | 1774 | 0.010 |
Why?
|
Diet | 2 | 2010 | 7939 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2011 | 3023 | 0.010 |
Why?
|
ROC Curve | 1 | 2007 | 3527 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2007 | 1738 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2002 | 1866 | 0.010 |
Why?
|
Sex Distribution | 1 | 2004 | 2297 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4042 | 0.010 |
Why?
|
Triglycerides | 1 | 2006 | 2454 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2915 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2002 | 1216 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2011 | 6993 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15997 | 0.010 |
Why?
|
Computational Biology | 1 | 2009 | 3521 | 0.010 |
Why?
|
Glucose | 1 | 2009 | 4397 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7322 | 0.010 |
Why?
|
Cochlea | 1 | 2002 | 828 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2005 | 1373 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3462 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2012 | 4258 | 0.010 |
Why?
|
Placenta | 1 | 2005 | 1698 | 0.010 |
Why?
|
Pedigree | 1 | 2003 | 4644 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2011 | 4034 | 0.010 |
Why?
|
Pre-Eclampsia | 1 | 2005 | 1200 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9583 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2002 | 1403 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2012 | 4644 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11483 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6364 | 0.010 |
Why?
|
DNA | 1 | 2008 | 7301 | 0.010 |
Why?
|
Schizophrenia | 1 | 2012 | 6882 | 0.010 |
Why?
|
MicroRNAs | 1 | 2009 | 3752 | 0.010 |
Why?
|
Hemorrhage | 1 | 2005 | 3461 | 0.010 |
Why?
|
Databases, Factual | 1 | 2006 | 7729 | 0.010 |
Why?
|
Mental Health | 1 | 2003 | 3019 | 0.010 |
Why?
|
Algorithms | 1 | 2008 | 13881 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 2004 | 5137 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2012 | 63114 | 0.000 |
Why?
|
Inflammation | 1 | 2005 | 10638 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2002 | 21827 | 0.000 |
Why?
|
Mice | 1 | 2002 | 81183 | 0.000 |
Why?
|